Harry Perkins Institute of Medical Research Inc
Concentration RiskAbout
The Harry Perkins Institute of Medical Research Inc. is a leading independent, not-for-profit medical research institute based in Western Australia. It focuses on conducting innovative research to prevent, diagnose, and treat life-altering diseases, particularly cancer, cardiovascular disease, diabetes, and rare genetic conditions. The Institute aims to translate its research breakthroughs into improved health outcomes for the community locally and globally.
Giving Philosophy
The Institute's approach to 'giving' is primarily through internal investment in world-class medical research, supporting its teams of scientists, clinicians, and students. They foster a culture of innovation and collaboration, aligning research with major health issues impacting West Australians. Key strategies include bringing together bright minds, discovering and trialling innovative treatments, utilizing precision medicine, and engaging with donors and supporters to fund their research programs and fellowships.
Tips for Applicants
To support the Harry Perkins Institute, align your contributions with their key research areas: cancer, cardiovascular disease and stroke, diabetes, and rare genetic diseases. They welcome major gift commitments of $10,000 or more, corporate partnerships, event sponsorships, and workplace giving programs. Direct donations and gifts in wills are also encouraged to foster innovative medical breakthroughs.
Programs & Opportunities (2)
Supports the next generation of Perkins researchers, with recipients for 2025 announced.
Supports students through their early medical research careers.
Notable Grants
- 2025 Safe Harbour Fellowships awarded to Dr Rowan Sanderson and Dr Rui Hou to support their research.
Financial History (7 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $32.6M | $36.9M | $142.7M | $-4,255,382 |
| 2022 | $29.7M | $30.2M | $142.4M | $-473,071 |
| 2021 | $27.7M | $27.6M | $141.7M | $144K |
| 2020 | $20.0M | $24.5M | $142.2M | $-4,514,857 |
| 2019 | $22.9M | $25.6M | $147.3M | $-2,769,138 |
| 2018 | $19.5M | $25.0M | $150.9M | $-5,504,017 |
| 2017 | $16.7M | $24.9M | $155.8M | $-8,234,506 |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-16823190402
- ABN
- 16823190402
- Sector
- health
- Website
- www.perkins.org.au
- Financial Year
- 2023
Focus Areas
Board & Leadership
- Hon Ben Morton - Chair
- Professor Peter Leedman AO - Director and Chief Executive Officer
- Professor Tim Colmer - Director
- Frank Cooper AO - Director
- Lorraine Driscoll - Director
- Rebecca Ostergaard - Director
- Val Raubenheimer - Director
- Yannick Spencer - Director
- Professor Joseph Trapani AO - Director
Financials
- Revenue
- $32.6M
- Assets
- $142.7M
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 28
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
Location Intelligence
- Postcode
- 6009
- Locality
- BROADWAY NEDLANDS
- Remoteness
- Major Cities of Australia
- SEIFA Disadvantage
- Decile 10/10
- LGA
- Perth
- SA2 Region
- Nedlands - Dalkeith - Crawley
- Entities in Area
- 460